SciTech Development LLC Competitors

Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans. Polaris' lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma. Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia. Polaris is also researching and developing other biotherapeutic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for the design of novel compounds that inhibit the biological function of cancer-related protein targets.

FLAG Therapeutics Inc., headquartered in Raleigh, North Carolina, is an early-stage oncology company focused on the development of therapies based on two novel classes of small molecule, water-soluble drugs. In vivo studies suggest that both classes of compounds, antiangiogenic/ anti-tubulin (AA/AT) compounds and folate-targeted anti-cancer (FTAC) compounds, hold the potential to treat multiple cancer types with greater safety and efficacy than conventional therapies. FLAG Therapeutics has obtained exclusive worldwide rights to these compounds from Duquesne University.

Velesco applies nimblocity to your early stage drug development projects, with our proven formulation of expertise, flexibility, dedication, and velocity to clinic. Expertise and experience Velesco is a CMC contract research organization, founded and staffed by pharmaceutical scientists from Pfizer's former Michigan R&D campus. Our team has experience with more than 100 drug development programs. Flexibility Our nimble processes and focused expertise enables us to overcome even the most challenging obstacles. Our team is responsive, accommodating, and eager to help you reach the full potential of your compound, quickly and efficiently. Personalized Partnerships We treat your project like it's our own and share everything from insightful observations to solutions for problematic analytic methods, to assistance with the FDA registration process. All our services are royalty-free. Velocity to clinic We're committed to getting your compound to the clinic on time. Our size, capacity, and expertise allow us to accommodate changes swiftly while maintaining control and quality. As experts in pharmaceutical analytical chemistry, drug formulation development, and cGMP clinical supply manufacture, Velesco scientists have a proven track record of moving compounds through the critical drug development process with nimblocity and unrivaled success.